Fox Chase Cancer Center News

PHILADELPHIA (June 24, 2022)—Sameer Patel, MD, FACS, chief of the Division of Plastic & Reconstructive Surgery at Fox Chase Cancer Center, was recently inducted into the American Association of Plastic Surgeons (AAPS).

PHILADELPHIA (June 23, 2022)—Fox Chase Cancer Center researchers have shown in a recent study that taking a new approach to targeting a well-established cancer-promoting pathway may be effective in stopping the progression of certain cancers.

PHILADELPHIA (June 21, 2022)—Erica Huelsmann, MD, a Gynecological Oncology Fellow at Fox Chase Cancer Center, has been awarded a 2022 Conquer Cancer Merit Award by Conquer Cancer, the ASCO Foundation. The prestigious award, given at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, supports researchers with projects that span many areas of cancer care, including precision medicine, palliative care, and breast cancer.

PHILADELPHIA (June 1, 2022)—African American/Black and white patients treated with similar first-line therapies for advanced kidney cancer experienced similar outcomes but different response rates, according to research from Fox Chase Cancer Center that will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

PHILADELPHIA (June 1, 2022)—Although women of African descent experience higher incidence and mortality from triple-negative breast cancer (TNBC) than women of other races or ethnicities, a recent study shows that the magnitudes of gene-specific risks of TNBC were similar across different racial/ethnic groups. Results from the study will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

PHILADELPHIA (May 26, 2022)—In a study published in the prestigious journal Nature, Fox Chase Cancer Center researchers have shown that a drug candidate may help re-initiate immune responses by mimicking influenza virus infections in patients whose cancer is unresponsive to immunotherapy.

PHILADELPHIA (May 25, 2022)—Laura Bukavina, MD, MPH, a Urologic Oncology Fellow at Fox Chase Cancer Center, has been awarded a 2022 Urology Care Foundation Research Scholar Award, which supports future research leaders and ensures they receive the necessary training and guidance for a successful research career. The Urology Care Foundation is the official foundation of the American Urological Association (AUA).

PHILADELPHIA (May 10, 2022)—In a study published today in the prestigious journal Cancer Research, Fox Chase Cancer Center researchers analyzed over 700 experimentally determined structures of the high-priority cancer targets KRAS, NRAS, and HRAS to facilitate drug discovery for these proteins.